Video Summary (AI-Assisted):
Photobiomodulation is increasingly being explored as an adjunct to neurological rehabilitation, with particular interest in how different wavelengths of light may influence cellular energy production, inflammation, circulation and nervous-system function.
In this webinar, clinician and educator Darren Barnes-Heath discusses how he combines low-level laser therapy with primitive reflex integration, sensory stimulation, manual therapy and neurological exercises when working with children with autism. His approach is based on the idea that treatment should not focus on the brain in isolation, but should consider the interaction between neurological function, the autonomic nervous system, mitochondrial activity, inflammation and the gastrointestinal system.
The presentation also highlights an important theme: photobiomodulation is not simply a question of applying as much light as possible. Wavelength, power, treatment duration, tissue depth and the physiological state of the patient may all influence the response.
What Is Photobiomodulation?
Photobiomodulation involves exposing tissue to specific wavelengths of light with the intention of influencing cellular processes.
Barnes-Heath compares the concept with medication. A drug can interact chemically with molecules in the body and alter their activity. Light can also interact with biological molecules, although through a very different mechanism.
Photons delivered by a laser can be absorbed by specific chromophores within cells. This absorbed energy may alter biochemical reactions and cellular signalling.
One of the most widely investigated targets is the mitochondrion.
Mitochondria are responsible for producing much of the adenosine triphosphate, or ATP, that cells use as an energy source. Neurons require substantial amounts of ATP to maintain membrane potentials, communicate with other cells and adapt to changing demands.
When mitochondrial function is impaired, cells may become less efficient at maintaining normal activity.
Photobiomodulation research has therefore focused heavily on whether particular wavelengths can influence mitochondrial metabolism.
Light and the Mitochondrial Electron Transport Chain
A major part of the webinar focuses on cytochrome c oxidase, sometimes called Complex IV of the mitochondrial electron transport chain.
The electron transport chain consists of several protein complexes involved in converting nutrients and oxygen into usable cellular energy.
Red and near-infrared light have been studied extensively because cytochrome c oxidase absorbs light within portions of these wavelength ranges.
According to the framework presented in the webinar, photobiomodulation may:
- influence cytochrome c oxidase activity;
- alter nitric oxide binding;
- influence ATP production;
- modify oxidative signalling;
- affect inflammatory signalling pathways;
- promote cellular repair mechanisms.
Barnes-Heath emphasises that the effects are unlikely to be explained by one pathway alone.
Photobiomodulation appears to influence several interacting cellular systems, making its biological effects considerably more complicated than simply “giving mitochondria more energy.”
Why Wavelength Matters
Different wavelengths penetrate tissue differently and interact with different biological molecules.
Visible light extends roughly from violet and blue wavelengths through green and red. Beyond visible red lies near-infrared light.
Barnes-Heath discusses four wavelength groups in particular:
Red light
Red wavelengths, particularly around the mid-600-nanometre range, are commonly used in photobiomodulation.
The webinar associates red light primarily with mitochondrial activity, inflammatory regulation and systemic signalling.
Because red wavelengths contain more photon energy than longer infrared wavelengths but penetrate less deeply, they may be useful where relatively superficial tissues or systemic photobiomodulatory effects are targeted.
Near-infrared light
Near-infrared wavelengths penetrate deeper into tissue than visible red light.
This has made near-infrared photobiomodulation particularly interesting in research involving the brain, stroke and traumatic brain injury.
Barnes-Heath highlights experimental research suggesting that near-infrared photobiomodulation may influence factors associated with neuronal survival and repair, including brain-derived neurotrophic factor and vascular signalling.
However, he repeatedly cautions against assuming that greater power automatically produces greater benefit.
Violet light
Violet light contains more photon energy and therefore interacts differently with biological tissue.
Barnes-Heath discusses its potential antimicrobial effects and its interactions with molecules such as porphyrins and flavins.
He suggests that violet wavelengths may have potential applications when clinicians are interested in microbial activity or upstream mitochondrial processes.
Because shorter wavelengths may also generate greater oxidative stress, dosage becomes especially important.
Green light
Green wavelengths receive comparatively less attention in conventional photobiomodulation discussions, but Barnes-Heath describes potential interactions with haemoglobin, myoglobin and cellular signalling pathways involved in circulation, fibroblast activity and collagen production.
He suggests that green, violet and red wavelengths may potentially complement one another by influencing different biological targets.
These proposed wavelength-specific applications should be viewed as a developing area rather than a universally established clinical protocol.
The Biphasic Dose Response
One of the most important concepts in the webinar is the biphasic dose response.
Photobiomodulation does not necessarily follow the principle that more treatment produces a stronger therapeutic effect.
Instead, biological responses may resemble a curve.
Too little energy may produce little effect.
An appropriate dose may produce a beneficial response.
Increasing the dose beyond that point may reduce the benefit, while excessive exposure may potentially produce undesirable effects.
Barnes-Heath therefore argues for caution with powerful devices, particularly when treatment is being applied over the brain or used with children.
He favours relatively low-power treatment and frequently moving the laser rather than concentrating high levels of energy over one location for prolonged periods.
The exact safe and effective dose depends on multiple variables, including wavelength, irradiance, treatment area, duration, pulsing and tissue characteristics. The webinar itself acknowledges that paediatric evidence remains limited.
What Does the Autism Research Show?
Barnes-Heath reviews several studies investigating photobiomodulation in autistic children.
One of the studies discussed used red low-level laser therapy delivered over the head. Treatment was provided twice weekly for four weeks.
Researchers evaluated children using the Aberrant Behavior Checklist.
According to the webinar, improvements were reported across several areas, including:
- irritability;
- lethargy and social withdrawal;
- stereotypical behaviours;
- hyperactivity;
- compliance;
- aspects of speech and communication.
Barnes-Heath notes that follow-up results appeared to suggest that some improvements persisted beyond the initial treatment period.
However, he also makes an important clinical observation: the results described in the study were stronger than the improvements he typically observes in practice.
Rather than presenting the study as proof that laser therapy reliably produces dramatic improvements in autism, he considers possible differences between research populations, lifestyle factors and clinical populations.
That distinction is important because small clinical trials do not automatically translate into predictable outcomes for every child.
Infrared LED Research
The webinar also examines studies using near-infrared LED devices rather than lasers.
One device consisted of an array positioned around the head, with an additional intranasal light source.
In one study described by Barnes-Heath, treatment occurred frequently over several months.
Changes appeared to be more modest than those reported in the earlier red-laser trial, although improvements were reported in areas such as ADHD-related behaviour and sleep.
Another study using near-infrared light reportedly showed more substantial changes and also investigated quantitative EEG measurements.
Some children experienced temporary increases in hyperactivity or headaches during the early treatment period.
Barnes-Heath uses these studies to reinforce an important principle: wavelength, power, delivery method and dose matter.
Two devices described broadly as “photobiomodulation” may produce very different biological exposures.
Laser Versus LED
Another distinction discussed in the presentation is the difference between lasers and LEDs.
A laser produces a relatively collimated beam, meaning the light remains concentrated and directional.
LED light spreads much more broadly.
Barnes-Heath believes this may partly explain why some laser studies appear to produce different outcomes from LED studies.
The clinical significance of coherence and collimation in photobiomodulation continues to be debated, and therapeutic effects have been demonstrated with both lasers and LEDs. The webinar therefore treats the distinction as relevant, but not as evidence that LEDs are ineffective.
Why Primitive Reflexes Matter
Photobiomodulation is only one component of Barnes-Heath’s clinical strategy.
A major part of his work involves primitive reflexes.
Primitive reflexes are automatic movement patterns present during infancy. They play important developmental roles early in life and normally become increasingly controlled as higher areas of the nervous system mature.
Barnes-Heath reports frequently observing retained or poorly integrated primitive reflex patterns in the autistic children he treats.
One example is the palmar grasp reflex.
Touching an infant’s palm normally produces an automatic grasp. This response is useful during early development, but later voluntary hand function requires increasingly sophisticated cortical control.
Barnes-Heath’s therapeutic objective is therefore not simply to repeatedly provoke a primitive reflex. Instead, he attempts to combine sensory stimulation with activities intended to encourage greater voluntary neurological control.
Starting With Sensory Regulation
Many autistic children seen in his clinic cannot initially participate in complicated exercises.
Some may be highly sensitive to touch, movement or stimulation around the face, head or feet.
Barnes-Heath therefore starts conservatively.
If sensory input immediately triggers withdrawal or distress, intensifying that stimulus may simply increase sympathetic arousal.
Instead, the first objective is often regulation.
The clinician may combine gentle sensory input with strategies intended to influence autonomic function, including stimulation associated with the vagal system.
As the child becomes more tolerant of sensation, the intensity and complexity of sensory stimulation can gradually increase.
Examples discussed in the webinar include brushing, vibration and proprioceptive stimulation.
Matching Photobiomodulation to Neurological Activity
An important feature of Barnes-Heath’s approach is that he does not view the laser as an isolated treatment.
Instead, he tries to apply photobiomodulation while particular neurological networks are being used.
During sensory activities, for example, cortical regions involved in processing sensory information are active.
During voluntary tasks, frontal and prefrontal networks become increasingly involved in planning and controlling behaviour.
The cerebellum contributes to coordination, timing and error correction.
Barnes-Heath’s clinical reasoning is therefore to combine activation of these systems with photobiomodulation.
The theory is straightforward: when neurons are actively working and their metabolic requirements increase, photobiomodulation may potentially support the cellular processes required by those active networks.
This remains a clinical hypothesis rather than a fully established autism treatment protocol.
The Role of the Cerebellum
The cerebellum receives particular attention.
Its role extends well beyond simple balance.
The cerebellum continuously compares intended movement with actual performance and contributes to movement correction, timing, learning and adaptation.
Barnes-Heath therefore incorporates cerebellar stimulation when children perform coordination exercises.
If a child is reaching for a target, balancing, tracking an object or responding to moving stimuli, the cerebellum is continuously processing errors and adjusting movement.
Photobiomodulation may then be applied over regions associated with these functions while the task is taking place.
Manual Therapy as a Neurological Stimulus
Manual therapy is another component of the programme.
Barnes-Heath discusses research suggesting that spinal manipulation and related manual interventions can temporarily modify sensory input to the central nervous system and influence activity in areas including the cerebellum and frontal cortex.
He does not suggest that manipulation alone “corrects” autism.
Instead, he describes manual treatment as a potential way of changing sensory input and temporarily increasing neurological responsiveness.
A typical treatment sequence might therefore involve:
vascular or systemic photobiomodulation → manual therapy → sensory or motor exercises → targeted photobiomodulation.
The objective is to combine multiple stimuli rather than relying on any one intervention.
Vestibular Rehabilitation
Vestibular problems are also commonly encountered in Barnes-Heath’s clinical population.
Some children may display difficulties involving balance, head movement, eye movements or visual tracking.
He therefore uses vestibular exercises alongside proprioceptive and visual tasks.
Examples include controlled movement, slow spinning, eye-tracking activities and games in which a child must identify and touch illuminated targets while moving.
During these exercises, photobiomodulation may be directed toward areas associated with cerebellar and vestibular processing.
The treatment is therefore intended to be active rather than passive wherever the child is capable of participating.
Why Barnes-Heath Is Cautious About Laser Frequencies
Photobiomodulation devices frequently offer pulsing at different frequencies.
Barnes-Heath is considerably more cautious about this aspect of treatment.
He argues that evidence comparing individual pulse frequencies remains limited.
For example, applying a laser pulsed at 40 Hz should not automatically be assumed to entrain the brain into 40-Hz gamma activity.
Visual and auditory stimulation can entrain neural oscillations because sensory receptors respond directly to rhythmic stimulation.
Photobiomodulation works differently.
Light applied transcranially is primarily interacting with biological molecules rather than stimulating retinal photoreceptors.
Barnes-Heath therefore sometimes matches laser frequency to other neurological stimulation being used simultaneously, but openly acknowledges that the evidence for the optimal frequency remains uncertain.
This willingness to distinguish established mechanisms from clinical experimentation is one of the more important messages of the presentation.
Autism Is Not Only About the Brain
Perhaps the broadest clinical argument in the webinar is that autism should not be viewed solely through the brain.
Barnes-Heath describes many of the children he sees as presenting with overlapping neurological, gastrointestinal, immune and metabolic difficulties.
The gut-brain relationship therefore becomes particularly important.
Communication between the gastrointestinal system and nervous system occurs in both directions through neural, endocrine, metabolic and immune pathways.
Brain injury research provides an example of this bidirectional relationship: neurological trauma can be followed by changes in intestinal permeability and gastrointestinal inflammatory signalling.
Likewise, alterations in the gut environment can influence systemic signalling that ultimately affects the nervous system.
Barnes-Heath therefore argues that clinicians should consider both sides of the relationship.
Photobiomodulation Over the Abdomen
The webinar describes using photobiomodulation over the abdomen as part of this broader strategy.
Barnes-Heath discusses experimental research suggesting that light exposure may influence the gut microbiome and gastrointestinal physiology.
He is particularly interested in combining red, violet and green wavelengths because of their proposed effects on mitochondrial activity, inflammatory regulation, microbial populations, circulation and tissue repair.
He also reports anecdotal changes in bowel movements among some children following treatment.
These observations are clinical anecdotes rather than proof that a specific microbial change has occurred. Changes in stool appearance or odour alone cannot establish that the intestinal microbiome has been altered.
Nevertheless, the observations have encouraged further interest in abdominal photobiomodulation and the gut-brain axis.
Systemic Photobiomodulation
One particularly interesting area discussed in the webinar is remote or systemic photobiomodulation.
Light does not necessarily have to be applied directly over the target organ for every biological effect to occur there.
Local photobiomodulation can trigger circulating signalling molecules, immune responses, vascular changes and other systemic effects.
Barnes-Heath compares this concept with sunlight stimulating vitamin D production in exposed skin while vitamin D subsequently influences tissues throughout the body.
Animal studies and experimental research have investigated whether photobiomodulation applied at one location can influence injury or neurological processes elsewhere.
For Barnes-Heath, this provides part of the rationale for treating blood vessels and peripheral tissues alongside direct transcranial applications.
Treating the Circulation Before the Brain
Another practical strategy discussed involves applying low-level light over major blood vessels before focusing on the brain.
The reasoning is that photobiomodulation may influence red blood cells, endothelial function, nitric oxide signalling and oxygen availability.
Barnes-Heath therefore sometimes applies light near the carotid circulation and posterior neck before moving to cortical or cerebellar targets.
He views this as a way of preparing the physiological environment before asking the brain to perform more demanding neurological tasks.
The Central Clinical Principle: Combine Interventions
The webinar ultimately presents photobiomodulation not as a standalone treatment for autism, but as an adjunct.
Barnes-Heath’s model combines several approaches:
- regulation of sensory hypersensitivity;
- primitive reflex work;
- manual therapy;
- vagal and autonomic stimulation;
- vestibular rehabilitation;
- proprioceptive stimulation;
- motor learning;
- cognitive tasks;
- cerebellar exercises;
- photobiomodulation;
- consideration of gastrointestinal and systemic health.
The intervention changes according to what the child can tolerate and actively participate in.
A child who is highly dysregulated may initially require predominantly passive and calming interventions.
As sensory tolerance improves, more active motor tasks can be introduced.
Eventually, greater emphasis can be placed on planning, attention, voluntary movement and cognitive control.
Photobiomodulation is then directed toward physiological and neurological systems believed to be active during each stage.
Why Lower Doses May Be More Appropriate
A recurring theme throughout the presentation is restraint.
Powerful lasers are not automatically superior.
Barnes-Heath favours lower-energy treatment, particularly when working with children, because it provides a wider margin before reaching potentially inhibitory or excessive doses.
Moving beams and pulsed delivery may also reduce the amount of energy accumulating in one location.
This is particularly important when working near the brain, major blood vessels or sensitive tissues.
His guiding principle is therefore to stimulate biological activity without overwhelming it.
What Practitioners Should Take From the Webinar
The presentation offers an intriguing framework for clinicians interested in photobiomodulation and developmental neurology, but it also exposes how much remains uncertain.
Research supports genuine biological effects of red and near-infrared photobiomodulation, particularly involving mitochondrial signalling, inflammation and tissue repair. Research into neurological applications is also expanding.
That is different, however, from establishing photobiomodulation as a proven treatment for the core features of autism.
The paediatric autism literature discussed in the webinar remains limited, with relatively small studies, differing devices, different wavelengths and substantially different treatment protocols.
Barnes-Heath himself repeatedly acknowledges these limitations.
His central argument is therefore less that one laser protocol “treats autism” and more that photobiomodulation may become another tool within a wider neurological rehabilitation strategy.
The Bigger Picture
The most valuable idea in the webinar may be the concept of matching treatment to physiology.
Instead of asking simply, “Which laser is best?”, Barnes-Heath encourages practitioners to ask more specific questions.
Which tissue is being targeted?
Which wavelength interacts most appropriately with it?
How much energy is required?
Is the child already physiologically overstimulated?
Which neurological networks are active during the treatment?
Is the intervention addressing the brain alone, or also considering autonomic, circulatory and gastrointestinal influences?
These questions turn photobiomodulation from a passive device-based treatment into part of a broader clinical strategy.
The emerging research is promising, but many questions surrounding paediatric dosage, wavelength combinations, treatment frequency and long-term outcomes remain unresolved.
For practitioners, that means enthusiasm should be accompanied by careful dosing, objective monitoring and an understanding that autism is a heterogeneous neurodevelopmental condition rather than a single physiological problem with a single solution.
Photobiomodulation may ultimately prove useful for selected physiological targets associated with autism and developmental rehabilitation. The evidence discussed in this webinar suggests reasons for continued research, while also making clear that clinical application should remain measured, individualised and evidence-aware.
